What is the new weight-loss drug Ozempic launched in India?
Click to start listening
Synopsis
Novo Nordisk has officially launched its revolutionary weight-loss drug, Ozempic, in India for Rs 8,800 monthly. This once-weekly injectable medication, approved for type 2 diabetes, also promotes weight loss and cardiovascular health. Discover how Ozempic is set to transform diabetes treatment in India.
Key Takeaways
- Ozempic is a once-weekly injection for type 2 diabetes management.
- Initial pricing starts at Rs 8,800 per month.
- Available in dosages of 0.25mg, 0.5mg, and 1mg.
- Designed with Novofine Needles for painless administration.
- Offers additional benefits for weight management and cardiovascular health.
New Delhi, Dec 12 (NationPress) Novo Nordisk unveiled its highly anticipated weight-loss medication Ozempic in India, with a monthly cost starting at Rs 8,800 for a four-week supply.
Ozempic is a once-weekly injectable treatment containing semaglutide, which has been approved in India for adults struggling with uncontrolled type 2 diabetes, in conjunction with diet and exercise.
The medication is offered in three dosage options: 0.25mg, 0.5mg, and 1mg, delivered via a user-friendly, single-use prefilled pen known as Novofine Needles, designed for a painless subcutaneous injection.
The 0.25mg initial dose is priced at Rs 8,800, whereas the 0.5mg and 1mg doses are priced at Rs 10,170 and Rs 11,175 respectively, with each pen containing four weekly doses.
“The launch of Ozempic in India represents a significant achievement. With international credibility, demonstrated clinical effectiveness, and top-tier quality, Ozempic provides Indian healthcare professionals with a reliable treatment alternative,” stated Vikrant Shrotriya, Managing Director of Novo Nordisk India.
He further added, “We aim to offer patients an innovative and readily accessible therapy that enhances glycemic control, effective weight management, and long-term heart and kidney protection—all through a simple, user-friendly pen device. This once-weekly treatment exemplifies Novo Nordisk’s unwavering commitment to improving health outcomes and managing chronic illnesses.”
Approved by the US Food and Drug Administration (FDA) in 2017 for type 2 diabetes, Ozempic has since gained popularity as an off-label treatment for weight reduction due to its appetite-suppressing properties. It is also noted for reducing the risk of cardiovascular incidents and kidney issues among patients.
The company highlighted that Ozempic acts as a GLP-1 receptor agonist, facilitating better glycemic control, lowering HbA1c levels (a key indicator of glucose regulation), managing appetite and food consumption through the brain regions that govern hunger, aiding weight loss for individuals with type 2 diabetes, and mitigating cardiovascular and renal complications tied to diabetes.
Point of View
I recognize the significance of Novo Nordisk's launch of Ozempic in India. This development not only opens new avenues for diabetes management but also addresses weight loss challenges faced by many. With a commitment to quality and patient care, Novo Nordisk's initiative aligns with our national health objectives, providing accessible treatments for chronic conditions.
NationPress
13/12/2025
Frequently Asked Questions
What is Ozempic used for?
Ozempic is primarily used for managing type 2 diabetes and has also become popular for weight loss due to its appetite-suppressing effects.
How much does Ozempic cost in India?
The cost of Ozempic in India starts at Rs 8,800 for the 0.25mg dosage for a month.
How often is Ozempic administered?
Ozempic is administered once a week via a simple injectable pen.
What are the side effects of Ozempic?
Common side effects may include nausea, diarrhea, and stomach pain. It's essential to consult a healthcare professional for a complete list.
Can Ozempic help with weight loss?
Yes, Ozempic has been shown to aid in weight loss, especially in individuals with type 2 diabetes.
